Closing the gap: How academic non-profits are making CGT manufacturing accessible (opens in new tab)

&#8230; from the beginning, and so <span class="match">industry</span> collaborators are essential.”  Partnering &#8230; has no board of <span class="match">investors</span> to please or profit &#8230; address that problem for <span class="match">Latin America</span>. Hematological malignancies are a leading &#8230; CD30 therapies and can <span class="match">produce</span> up to 200 doses &#8230;